Related Experiment Video
Updated: Jun 27, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Attention deficit hyperactivity disorder symptoms mediate early-onset smoking
A C Huizink1, P A C van Lier, A A M Crijnen
1Erasmus Medical Center Rotterdam/Sophia Children's Hospital, Department of Child and Adolescent Psychiatry, Rotterdam, The Netherlands. a.c.huizink@erasmusmc.nl
Reducing attention deficit hyperactivity disorder (ADHD) symptoms in children through interventions can decrease the risk of early-onset smoking. This study found ADHD symptom reduction fully mediated the intervention
Area of Science:
- Child Psychology
- Behavioral Science
- Public Health
Background:
- Attention deficit hyperactivity disorder (ADHD) symptoms are linked to early-onset smoking.
- Understanding the mediating factors between ADHD and smoking is crucial for prevention.
Purpose of the Study:
- To investigate if reductions in ADHD symptoms mediate the reduced risk of early-onset smoking.
- To examine the impact of a school-based intervention on ADHD symptoms and subsequent tobacco use.
Main Methods:
- A universal, school-based randomized controlled trial involving 477 first-grade children.
- The Good Behavior Game intervention targeted disruptive behavior problems over two years.
- ADHD symptoms were assessed via teacher ratings, and tobacco use via self-report.
Main Results:
- Intervention-induced reductions in ADHD symptoms fully mediated the effect of the intervention on reduced early-onset smoking.
Conclusions:
- Interventions targeting ADHD symptoms may serve as a protective factor against early-onset smoking.
- Further research is warranted to elucidate the pathways from ADHD symptoms to tobacco use.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine
